Ota, Vanessa Kiyomi
Santoro, Marcos Leite
Spindola, Leticia Maria
Pan, Pedro Mario
Simabucuro, Andressa
Xavier, Gabriela http://orcid.org/0000-0002-5311-3039
Vieira-Fonseca, Tamiris
Zanardo, Evelin Aline http://orcid.org/0000-0002-5624-8158
dos Santos, Felipe Rodolfo Camargo
Schäfer, Julia Luiza
Kulikowski, Leslie Domenici
Galante, Pedro A. F.
Asprino, Paula Fontes
Brietzke, Elisa
Grassi-Oliveira, Rodrigo http://orcid.org/0000-0001-9911-5921
Rohde, Luis Augusto
Miguel, Euripedes Constantino
Gadelha, Ary
Mari, Jair Jesus
Bressan, Rodrigo Affonseca
Salum, Giovanni Abrahao
Belangero, Sintia Iole
Article History
Received: 14 October 2019
Revised: 14 February 2020
Accepted: 27 February 2020
First Online: 17 March 2020
Conflict of interest
: L.A.R. has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Eli Lilly and Co., Janssen, Medice, Novartis and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by L.A.R. have received unrestricted educational and research support from the following pharmaceutical companies: Eli Lilly and Co., Janssen, and Novartis. L.A.R. has received authorship royalties from Oxford Press and ArtMed and travel grants from Shire to take part in the 2018 APA annual meeting and from Novartis to take part of the 2016 AACAP annual meeting. E.B. has received honoraria as speaker/consults from Daiichi-Sankyo and from the elaboration of educational material from Daiichi-Sankyo, Ache, Eurofarma, and Sanofi. In the last five years, R.A.B. has received research grants from Janssen Cilag, Roche and the governmental funding research agencies: CAPES, CNPq and FAPESP (2016/022465 and 2011/50740-5); has been a forum consultant for Janssen and Roche; and has participated in speaker bureaus for Ache, Janssen and Lundbeck, all outside the submitted work. The other authors have nothing to disclose.